U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07710768) titled 'A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight' on July 13.
Brief Summary: The purpose of this clinical study is to find out if UBT251 is safe and effective to be taken together with medicines, like midazolam, caffeine and warfarin in participants living with overweight or obesity.
Study Start Date: July 15
Study Type: INTERVENTIONAL
Condition:
Obesity
Overweight
Intervention:
DRUG: UBT251
Administered subcutaneously.
DRUG: Cocktail (Warfarin/Caffeine/Midazolam)
Administered orally.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Novo ...